← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Allander Biotechnologies, Inc.
Aurora, CO
$8,395,834
Total funding
5
Grants
Funding over time
peak $1.5M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,395,834 · 5
By mechanism
R44$5,925,801 · 4
SB1$2,470,033 · 1
Investigators at Allander Biotechnologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients$1,239,748
SB1 · FY2023 · DE
First-in-human clinical trial of proprietary oral gel to treat radiation-induced oral mucositis in cancer patients$1,233,852
R44 · FY2025 · CA
IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients$1,230,285
SB1 · FY2024 · DE
Proprietary drug to treat radiodermatitis$1,157,986
R44 · FY2020 · AR
Topical proprietary biologic to treat oral mucositis$797,137
R44 · FY2017 · DE
Proprietary biologic treatment to heal skin wounds$796,049
R44 · FY2018 · DE
Proprietary biologic treatment to heal skin wounds$715,021
R44 · FY2019 · DE
Topical proprietary biologic to treat oral mucositis$702,863
R44 · FY2018 · DE
Proprietary drug to treat radiodermatitis$522,893
R44 · FY2021 · AR